BIOEX — Bioextrax AB publ Share Price
Last trade - 00:00- SEK96.63m
- SEK79.37m
- SEK0.52m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.71 | ||
| Price to Tang. Book | 3.71 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 187.64 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -67.3% | ||
| Return on Equity | -74.42% | ||
| Operating Margin | -3405.63% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 0.02 | 0.28 | 0.4 | 2.06 | 0.52 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioextrax AB (publ) is a Sweden-based biotech research company. The Company specializes in research and development of technology platforms that are used to convert organic waste into various environmentally friendly materials. Bioextrax AB (publ) develops a potent microbial extraction technology, which is realized through applications such as Bioplastics (PHA), Organic Hydrolyzed Protein and Keratin Fibers.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 14th, 2014
- Public Since
- April 28th, 2020
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 39,123,072
- Address
- Skiffervagen 76, LUND, 224 78
- Web
- https://bioextrax.com/
- Phone
- +46 406170999
- Auditors
- Ernst & Young AB
Upcoming Events for BIOEX
Similar to BIOEX
Absolent Air Care AB
OMX Nordic Exchange Stockholm
Afry AB
OMX Nordic Exchange Stockholm
Aino Health AB (publ)
OMX Nordic Exchange Stockholm
Aker Carbon Capture ASA
OMX Nordic Exchange Stockholm
Arribatec ASA
OMX Nordic Exchange Stockholm
FAQ
As of Today at 19:35 UTC, shares in Bioextrax AB publ are trading at SEK2.47. This share price information is delayed by 15 minutes.
Shares in Bioextrax AB publ last closed at SEK2.47 and the price had moved by -2.31% over the past 365 days. In terms of relative price strength the Bioextrax AB publ share price has underperformed the FTSE Global All Cap Index by -4.75% over the past year.
There is no consensus recommendation for this security.
Find out moreBioextrax AB publ does not currently pay a dividend.
Bioextrax AB publ does not currently pay a dividend.
Bioextrax AB publ does not currently pay a dividend.
To buy shares in Bioextrax AB publ you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK2.47, shares in Bioextrax AB publ had a market capitalisation of SEK96.63m.
Here are the trading details for Bioextrax AB publ:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: BIOEX
Based on an overall assessment of its quality, value and momentum Bioextrax AB publ is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioextrax AB publ. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -26.09%.
As of the last closing price of SEK2.47, shares in Bioextrax AB publ were trading -22.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioextrax AB publ PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK2.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Bioextrax AB publ's directors